BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11987821)

  • 1. Innate immune responses to LCMV infections: natural killer cells and cytokines.
    Biron CA; Nguyen KB; Pien GC
    Curr Top Microbiol Immunol; 2002; 263():7-27. PubMed ID: 11987821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-27R Signaling Mediates Early Viral Containment and Impacts Innate and Adaptive Immunity after Chronic Lymphocytic Choriomeningitis Virus Infection.
    Harker JA; Wong KA; Dallari S; Bao P; Dolgoter A; Jo Y; Wehrens EJ; Macal M; Zuniga EI
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29593047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 1 interferon induction of natural killer cell gamma interferon production for defense during lymphocytic choriomeningitis virus infection.
    Mack EA; Kallal LE; Demers DA; Biron CA
    mBio; 2011; 2(4):. PubMed ID: 21828218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD8 T cells in innate immune responses: using STAT4-dependent but antigen-independent pathways to gamma interferon during viral infection.
    Suarez-Ramirez JE; Tarrio ML; Kim K; Demers DA; Biron CA
    mBio; 2014 Oct; 5(5):e01978-14. PubMed ID: 25336459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compartmental differences in NK cell responsiveness to IL-12 during lymphocytic choriomeningitis virus infection.
    Pien GC; Biron CA
    J Immunol; 2000 Jan; 164(2):994-1001. PubMed ID: 10623849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine-Mediated Activation of NK Cells during Viral Infection.
    Freeman BE; Raué HP; Hill AB; Slifka MK
    J Virol; 2015 Aug; 89(15):7922-31. PubMed ID: 25995253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An absolute and restricted requirement for IL-12 in natural killer cell IFN-gamma production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections.
    Orange JS; Biron CA
    J Immunol; 1996 Feb; 156(3):1138-42. PubMed ID: 8557990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-12 is not required for induction of type 1 cytokine responses in viral infections.
    Oxenius A; Karrer U; Zinkernagel RM; Hengartner H
    J Immunol; 1999 Jan; 162(2):965-73. PubMed ID: 9916721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constitutive but not inducible attenuation of transforming growth factor β signaling increases natural killer cell responses without directly affecting dendritic cells early after persistent viral infection.
    Lewis GM; Macal M; Hesser CR; Zuñiga EI
    J Virol; 2015 Mar; 89(6):3343-55. PubMed ID: 25589641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergism for cytokine-mediated disease during concurrent endotoxin and viral challenges: roles for NK and T cell IFN-gamma production.
    Nguyen KB; Biron CA
    J Immunol; 1999 May; 162(9):5238-46. PubMed ID: 10227998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inability of interferon to protect virus-infected cells against lysis by natural killer (NK) cells correlates with NK cell-mediated antiviral effects in vivo.
    Bukowski JF; Welsh RM
    J Immunol; 1985 Nov; 135(5):3537-41. PubMed ID: 2413125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD47 Expression in Natural Killer Cells Regulates Homeostasis and Modulates Immune Response to Lymphocytic Choriomeningitis Virus.
    Nath PR; Gangaplara A; Pal-Nath D; Mandal A; Maric D; Sipes JM; Cam M; Shevach EM; Roberts DD
    Front Immunol; 2018; 9():2985. PubMed ID: 30643501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type I interferons protect T cells against NK cell attack mediated by the activating receptor NCR1.
    Crouse J; Bedenikovic G; Wiesel M; Ibberson M; Xenarios I; Von Laer D; Kalinke U; Vivier E; Jonjic S; Oxenius A
    Immunity; 2014 Jun; 40(6):961-73. PubMed ID: 24909889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of correlation between serum titres of interferon alpha, beta, natural killer cell activity and clinical susceptibility in mice infected with two isolates of lymphocytic choriomeningitis virus.
    Leist TP; Aguet M; Hässig M; Pevear DC; Pfau CJ; Zinkernagel RM
    J Gen Virol; 1987 Aug; 68 ( Pt 8)():2213-8. PubMed ID: 3612089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon alpha/beta and interleukin 12 responses to viral infections: pathways regulating dendritic cell cytokine expression in vivo.
    Dalod M; Salazar-Mather TP; Malmgaard L; Lewis C; Asselin-Paturel C; Brière F; Trinchieri G; Biron CA
    J Exp Med; 2002 Feb; 195(4):517-28. PubMed ID: 11854364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the immunomodulatory and antiviral effects of the cytokine combination IFN-α and IL-7 in the lymphocytic choriomeningitis virus and Friend retrovirus mouse infection models.
    Audigé A; Hofer U; Dittmer U; van den Broek M; Speck RF
    Viral Immunol; 2011 Oct; 24(5):375-85. PubMed ID: 21929334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic cells induced during lymphocytic choriomeningitis virus infection of mice. I. Characterization of natural killer cell induction.
    Welsh RM
    J Exp Med; 1978 Jul; 148(1):163-81. PubMed ID: 307587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MyD88 is critical for the development of innate and adaptive immunity during acute lymphocytic choriomeningitis virus infection.
    Zhou S; Kurt-Jones EA; Mandell L; Cerny A; Chan M; Golenbock DT; Finberg RW
    Eur J Immunol; 2005 Mar; 35(3):822-30. PubMed ID: 15724245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virus-induced transient bone marrow aplasia: major role of interferon-alpha/beta during acute infection with the noncytopathic lymphocytic choriomeningitis virus.
    Binder D; Fehr J; Hengartner H; Zinkernagel RM
    J Exp Med; 1997 Feb; 185(3):517-30. PubMed ID: 9053452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A role for IFN-alpha beta in virus infection-induced sensitization to endotoxin.
    Doughty L; Nguyen K; Durbin J; Biron C
    J Immunol; 2001 Feb; 166(4):2658-64. PubMed ID: 11160329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.